IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+39.2%
5Y CAGR+33.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+39.2%/yr
vs +54.9%/yr prior
5Y CAGR
+33.6%/yr
Recent acceleration
Acceleration
-15.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$58.73M+65.6%
2024$35.47M+46.0%
2023$24.30M+11.5%
2022$21.80M+18.9%
2021$18.33M+32.8%
2020$13.80M+58.5%
2019$8.71M+130.2%
2018$3.78M+127.4%
2017$1.66M-